FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1372-1376 May 13, 1993 Number 19 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Blood transfusions may adversely affect the prognosis of patients treated surgically for cancer, although definite proof of this adverse effect has not been reported.

Methods We carried out a randomized trial to investigate whether the prognosis in patients with colorectal cancer would be improved by a program of autologous blood transfusion as compared with the current practice of allogeneic transfusion. Patients in the autologous-transfusion group were required to donate two units of blood before surgery.

Results A total of 475 patients were evaluated. We found no significant difference in prognosis between the allogeneic-transfusion group (236 patients) and the autologous-transfusion group (239 patients); colorectal cancer-specific survival rates at four years were 67 percent and 62 percent, respectively (P = 0.39). Among the 423 patients who underwent curative surgery, 66 percent of those in the allogeneic-transfusion group and 63 percent of those in the autologous-transfusion group had no recurrence of colorectal cancer at four years (P = 0.93). We also found that the risk of recurrence was significantly increased in patients who received blood transfusions, either allogeneic or autologous, as compared with patients who did not require transfusions; the relative rates of recurrence were 2.1 (P = 0.01) and 1.8 (P = 0.04), respectively; these rates did not differ significantly from each other.

Conclusions The use of autologous blood as compared with allogeneic blood for transfusion does not improve the prognosis in patients with colorectal cancer. Regardless of their type, transfusions are associated with poor prognosis, probably because of the circumstances that necessitate them.

Source Information

From the Department of Surgery, University Hospital Rotterdam-Dijkzigt and Erasmus University (O.R.C.B., M.A.W.H.P., R.L.M., J.J.), and the Department of Epidemiology and Biostatistics, Erasmus University (W.C.J.H.), Rotterdam, the Netherlands.

Address reprint requests to Dr. Jeekel at the Department of Surgery, University Hospital Rotterdam-Dijkzigt, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.

Full Text of this Article

Related Letters:

Blood Transfusions and Prognosis in Colorectal Cancer
Ross W. B., Blumberg N., Heal J. M., Busch O. R.C., Marquet R. L., Hop W. C.J., Jeekel J.
Extract | Full Text  
N Engl J Med 1993; 329:1354-1356, Oct 28, 1993. Correspondence

This article has been cited by other articles:

• Perry, K. A., Enestvedt, C. K., Pham, T., Welker, M., Jobe, B. A., Hunter, J. G., Sheppard, B. C. (2009). Comparison of Laparoscopic Inversion Esophagectomy and Open Transhiatal Esophagectomy for High-Grade Dysplasia and Stage I Esophageal Adenocarcinoma. Arch Surg 144: 679-684 [Abstract] [Full Text]  
• Kazanjian, K. K., Hines, O. J., Duffy, J. P., Yoon, D. Y., Cortina, G., Reber, H. A. (2008). Improved Survival Following Pancreaticoduodenectomy to Treat Adenocarcinoma of the Pancreas: The Influence of Operative Blood Loss. Arch Surg 143: 1166-1171 [Abstract] [Full Text]  
• Brown, J. R., Birkmeyer, N. J.O., O'Connor, G. T. (2007). Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery. Circulation 115: 2801-2813 [Abstract] [Full Text]  
• Abbrederis, K., Bassermann, F., Schuhmacher, C., Voelter, V., Busch, R., Roethling, N., Sendler, A., Siewert, J. R., Peschel, C., Lordick, F. (2006). Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.. Ann. Thorac. Surg. 82: 293-297 [Abstract] [Full Text]  
• Spiess, B. D. (2004). Transfusion of Blood Products Affects Outcome in Cardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 8: 267-281 [Abstract]  
• Voelter, V., Schuhmacher, C., Busch, R., Peschel, C., Siewert, J. R., Lordick, F. (2004). Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer. Ann. Thorac. Surg. 78: 1037-1041 [Abstract] [Full Text]  
• Kuhry, E., Jeekel, J., Bonjer, H. J. (2004). Effect of Laparoscopy on the Immune System. SURG INNOV 11: 37-44 [Abstract]  
• Rzyman, W., Dziadziuszko, R., Skokowski, J., Wilimski, R., Raiter, A., Szymanowska, A., Jassem, J. (2003). The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J. Thorac. Cardiovasc. Surg. 126: 755-760 [Abstract] [Full Text]  
• Ghio, M., Ottonello, L., Contini, P., Amelotti, M., Mazzei, C., Indiveri, F., Puppo, F., Dallegri, F. (2003). Transforming growth factor-{beta}1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 102: 1100-1107 [Abstract] [Full Text]  
• Nosotti, M., Rebulla, P., Riccardi, D., Baisi, A., Bellaviti, N., Rosso, L., Santambrogio, L. (2003). Correlation Between Perioperative Blood Transfusion and Prognosis of Patients Subjected to Surgery for Stage I Lung Cancer. Chest 124: 102-107 [Abstract] [Full Text]  
• Carson, J. L. (2002). Should Patients in Intensive Care Units Receive Erythropoietin?. JAMA 288: 2884-2886 [Full Text]  
• Speiss, B. D. (2002). Transfusion and outcome in heart surgery. Ann. Thorac. Surg. 74: 986-987 [Full Text]  
• Langley, S. M., Alexiou, C., Bailey, D. H., Weeden, D. F. (2002). The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Ann. Thorac. Surg. 73: 1704-1709 [Abstract] [Full Text]  
• Vanderlinde, E. S, Heal, J. M, Blumberg, N. (2002). Autologous transfusion. BMJ 324: 772-775 [Full Text]  
• Lin, H.-S., Samy, R. N., Lum, J., Dorie, M. J., Terris, D. J. (2002). Effect of Blood Transfusion in an Experimental Sarcoma Model. Arch Otolaryngol Head Neck Surg 128: 308-312 [Abstract] [Full Text]  
• Baron, J.-F., Gourdin, M., Bertrand, M., Mercadier, A., Delort, J., Kieffer, E., Coriat, P. (2002). The Effect of Universal Leukodepletion of Packed Red Blood Cells on Postoperative Infections in High-Risk Patients Undergoing Abdominal Aortic Surgery. Anesth. Analg. 94: 529-537 [Abstract] [Full Text]  
• Spiess, B. D. (2001). Blood transfusion: the silent epidemic. Ann. Thorac. Surg. 72: S1832-1837 [Abstract] [Full Text]  
• Nicol, G., Hunt, E., Manji, M. (2001). When to give blood. Trauma 3: 221-233 [Abstract]  
• Vamvakas, E. C., Blajchman, M. A. (2001). Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?. Blood 97: 1180-1195 [Full Text]  
• Moir, M. S., Samy, R. N., Hanasono, M. M., Terris, D. J. (1999). Autologous and Heterologous Blood Transfusion in Head and Neck Cancer Surgery. Arch Otolaryngol Head Neck Surg 125: 864-868 [Abstract] [Full Text]  
• Ghio, M., Contini, P., Mazzei, C., Brenci, S., Barberis, G., Filaci, G., Indiveri, F., Puppo, F. (1999). Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A Possible Key to Explain the Immunomodulatory Effects of Allogeneic Blood Transfusions. Blood 93: 1770-1777 [Abstract] [Full Text]  
• Goodnough, L. T., Brecher, M. E., Kanter, M. H., AuBuchon, J. P. (1999). Transfusion Medicine -- Blood Transfusion- First of Two Parts. NEJM 340: 438-447 [Full Text]  
• Craig, S. R., Adam, D. J., Yap, P. L., Leaver, H. A., Elton, R. A., Cameron, E. W.J., Sang, C. T.M., Walker, W. S. (1998). Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann. Thorac. Surg. 66: 356-361 [Abstract] [Full Text]  
• Carter, A. S., Bunce, M., Cerundolo, L., Welsh, K. I., Morris, P. J., Fuggle, S. V. (1998). Detection of Microchimerism After Allogeneic Blood Transfusion Using Nested Polymerase Chain Reaction Amplification With Sequence-Specific Primers (PCR-SSP): A Cautionary Tale. Blood 92: 683-689 [Abstract] [Full Text]  
• Forgie, M. A., Wells, P. S., Laupacis, A., Fergusson, D., for the International Study of Perioperative Trans, (1998). Preoperative Autologous Donation Decreases Allogeneic Transfusion but Increases Exposure to All Red Blood Cell Transfusion: Results of a Meta-analysis. Arch Intern Med 158: 610-616 [Abstract] [Full Text]  
• Cunningham, J. D., Fong, Y., Shriver, C., Melendez, J., Marx, W. L., Blumgart, L. H. (1994). One Hundred Consecutive Hepatic Resections: Blood Loss, Transfusion, and Operative Technique. Arch Surg 129: 1050-1056 [Abstract]  
• Ross, W. B., Blumberg, N., Heal, J. M., Busch, O. R.C., Marquet, R. L., Hop, W. C.J., Jeekel, J. (1993). Blood Transfusions and Prognosis in Colorectal Cancer. NEJM 329: 1354-1356 [Full Text]  
• Toy, P. T.C.Y. (1993). Expert Commentary. PERSPECT VASC SURG ENDOVASC THER 6: 44-47